Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable)), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
상품코드:1671380
리서치사:MarketsandMarkets
발행일:2025년 03월
페이지 정보:영문 504 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 생검 기기 시장 규모는 2024년 72억 7,000만 달러에서 2030년에는 110억 1,000만 달러에 달할 것으로 예측되며, 예측 기간 중 CAGR은 7.2%에 달할 것으로 보이고 있습니다.
조사 범위
조사 대상연도
2024-2030년
기준연도
2023년
예측 기간
2024-2030년
검토 단위
금액(10억 달러)
부문
제품별, 기술별, 최종사용자별, 지역별
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, GCC 국가
특히 유방암, 폐암, 전립선암 등 정확하고 빠른 진단 검사가 필요한 암의 발병률이 높아지고 있는 것이 가장 큰 촉진요인 중 하나입니다. 세계보건기구(WHO)는 2030년까지 암 환자가 크게 증가할 가능성이 높다고 합니다. 따라서 생검 기기 수요는 증가할 것으로 예상됩니다. 또한 보다 최소침습적인 시술에 대한 수요 증가는 시장 성장을 더욱 촉진하고 있습니다. 진공 보조 생검이나 액체생검과 같은 새로운 생검 방법은 더 정확하고 회복 시간이 짧아 환자의 불편함을 줄여줍니다. 또한 로봇 보조 생검 기기, AI 기반 진단 시스템, 영상 유도 생검술과 같은 기술 발전은 정확성과 효율성을 향상시켜 시장 성장을 더욱 촉진할 것입니다. 또한 암 검진에 대한 정부 프로그램 증가와 특히 신흥 국가의 의료비 지출 증가가 결합하여 시장의 발전을 촉진하고 있습니다. 그러나 고급 생검 기기의 높은 가격과 엄격한 규제 환경은 제약 요인이 될 수 있습니다.
생검 기기 시장은 제품별로 바늘 생검 기기, 시각화 장비, 브러시 생검 기기, 생검 액세서리, 로봇 생검 기기로 나뉩니다. 이 중 2023년에는 바늘 생검 기기 부문이 생검 기기 시장에서 7.8%로 가장 높은 성장률을 나타낼 것으로 예상됩니다. 이는 저침습적 진단 개입에 대한 선호도가 높아졌기 때문입니다. 코어니들생검(CNB), 미세침흡입생검(FNAB), 진공보조생검(VAB)과 같은 바늘생검 기기는 외과적 생검을 대체할 수 있는 저침습적이고 고통이 적은 생검을 제공합니다. 이를 통해 환자의 고통, 회복 시간, 시술 비용을 줄일 수 있습니다. 또한 질병의 조기 발견과 정밀의료에 대한 관심이 높아지면서 합병증이 적고 매우 정확한 조직 샘플을 얻을 수 있는 바늘 생검에 대한 수요도 증가하고 있습니다. 또한 생검을 위한 외래 및 외래 시설 중심의 추세도 바늘 생검이 신속하고 인프라를 거의 필요로 하지 않기 때문에 시장을 확대하고 있습니다. 그러나 출혈, 감염, 샘플링 오류의 위험은 이 시장의 성장에 도전이 되고 있습니다.
용도별로 생검장비 시장은 종양, 소화기, 뼈 및 골수 생검, 기타 용도로 구분됩니다. 소화기 분야는 생검 기기 시장에서 두 번째로 큰 시장 점유율을 차지하고 있습니다. 이는 소화관(GI) 질환 증가와 내시경 생검법의 기술적 진보에 기인합니다. 또한 대장암, 위암, 염증성장질환(IBD), 체강내 질환, 소화관 감염과 같은 소화관 질환은 적절한 진단을 위해 생검이 필요합니다. 또한 전 세계에서 가장 재발률이 높은 암 중 하나인 대장암의 발생률 증가가 소화관 생검 기기의 필요성에 크게 기여하고 있습니다. 또한 영상 유도하 생검법, 즉 초음파 내시경 유도하 미세침흡입술(EUS-FNA)과 미세침 생검(EUS-FNB)의 사용이 증가하고 있으며, 뿌리 깊은 소화기 종양의 진단 정확도가 향상되어 시장 성장에 기여하고 있습니다. 또한 소화기 질환을 앓고 있는 노령 인구 증가와 세계 수준의 의료 인프라 발전도 시장 성장을 가속하고 있습니다.
세계의 생검 기기 시장에 대해 조사했으며, 제품별, 기술별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 개요
제4장 주요 인사이트
제5장 시장 개요
서론
시장 역학
업계 동향
기술 분석
Porter's Five Forces 분석
규제 상황
특허 분석
무역 분석
가격 분석
주요 컨퍼런스와 이벤트
주요 이해관계자와 구입 기준
생검 기기 시장 : 최종사용자 미충족 요구/기대
에코시스템 분석
사례 연구 분석
공급망 분석
인접 시장 분석
고객 비즈니스에 영향을 미치는 동향/혼란
투자와 자금조달 시나리오
생검 기기 시장에서 AI의 영향
제6장 생검 기기 시장(제품별)
서론
침생검 기기
가시화 기기/시스템
브러시 생검 기기
생검 액세서리
로봇 생검 기기
제7장 생검 기기 시장(기술별)
서론
초음파 유도하 생검
정위 유도하 생검
기타
제8장 생검 기기 시장(용도별)
서론
종양과
소화기 내과
뼈 및 골수 생검
기타
제9장 생검 기기 시장(최종사용자별)
서론
병원과 유방 케어 센터
진단 영상 센터
외래 수술 센터
기타
제10장 생검 기기 시장(지역별)
서론
북미
거시경제 전망
미국
캐나다
유럽
거시경제 전망
독일
영국
프랑스
이탈리아
스페인
기타
아시아태평양
거시경제 전망
중국
일본
인도
호주
한국
기타
라틴아메리카
거시경제 전망
브라질
멕시코
기타
중동 및 아프리카
거시경제 전망
GCC 국가
기타
제11장 경쟁 구도
개요
주요 참여 기업의 전략/강점
매출 분석
시장 점유율 분석
기업 평가 매트릭스 : 주요 참여 기업, 2023년
기업 평가 매트릭스 : 스타트업/중소기업, 2023년
기업 평가와 재무 지표
브랜드/제품 비교
경쟁 시나리오
제12장 기업 개요
주요 참여 기업
BD(BECTON, DICKINSON AND COMPANY)
DEVICOR MEDICAL PRODUCTS, INC
MEDTRONIC
CARDINAL HEALTH
HOLOGIC, INC.
B. BRAUN SE
OLYMPUS CORPORATION
BOSTON SCIENTIFIC CORPORATION
FUJIFILM CORPORATION
STRYKER
TELEFLEX INCORPORATED
CONMED CORPORATION
MERIT MEDICAL SYSTEMS
JOHNSON & JOHNSON SERVICES, INC.
COOK GROUP
기타 기업
MICROPORT SCIENTIFIC CORPORATION
ARGON MEDICAL DEVICES
INRAD, INC.
SUMMIT MEDICAL LLC
TRANSMED7, LLC
DR. JAPAN CO., LTD.
IZI MEDICAL PRODUCTS
PLANMED OY
ADVIN HEALTH CARE
TRIVITRON HEALTHCARE
제13장 부록
KSA
영문 목차
영문목차
The global biopsy device market is projected to reach USD 11.01 billion by 2030 from USD 7.27 billion in 2024, at a CAGR of 7.2% during the forecast period."
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2023
Forecast Period
2024-2030
Units Considered
Value (USD Billion)
Segments
Product, Technology, Application, End User, and Region
Regions covered
North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries
One of the biggest drivers is the growing incidence of cancer, especially breast, lung, and prostate cancers, which need precise and early diagnostic tests. The World Health Organization states that cancer cases are likely to increase substantially by 2030. Therefore, there would be an increasing demand for biopsy devices. Also, the growing demand for less invasive procedures is driving market growth further. The newer biopsy methods like vacuum-assisted and liquid biopsies are more accurate, have lower recovery times, and cause lower patient discomfort Furthermore, advances in technology, such as robotic-assisted biopsy machines, AI-based diagnostic systems, and image-guided biopsy procedures, improve accuracy and efficiency, driving market growth further. Moreover, rising government programs for cancer screening, combined with rising healthcare spending, especially in developing nations, drive the market forward. Nonetheless, the high prices of sophisticated biopsy devices and strict regulatory environments can serve as constraints.
"The needle-based biopsy instrument segment to grow the fastest during the forecast period."
Based on the product, the biopsy device market is divided into Needle-based biopsy instrument, Visualization device, Brush biopsy instrument, Biopsy accessory and Robotic biopsy device. Among these, in 2023, Needle-based biopsy instrument segment account for the highest growing segment of 7.8% in biopsy device market. This is due to rising preference for the utilization of minimally invasive diagnostic interventions. The Needle biopsy devices such as core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB) devices provide a less painful and less invasive alternative to surgical biopsies. This lowers patient pain, recovery time, and procedural expenses. Moreover, the growing focus on early disease detection and precision medicine has also driven demand for needle biopsies, as they yield very accurate tissue samples with few complications. Further, the increasing trend towards ambulatory and outpatient facilities for biopsies has also increased the market, as needle biopsies are quick and require little infrastructure. However, the risks of bleeding, infection, and sampling errors pose challenges to the growth of this market.
"The gastroenterology segment accounts for the second largest market share in biopsy device market."
Based on application, the biopsy device market is segmented into oncology, Gastroenterology, Bone & Bone marrow biopsy and other applications. The gastroenterology segment accounts for the second largest market share in biopsy device market. This can be attributed to the growing cased of gastrointestinal (GI) diseases and technological advancements in endoscopic biopsy methods. Moreover, the GI disorders such as Colorectal cancer, gastric cancer, inflammatory bowel disease (IBD), celiac disease, and gastrointestinal infections need biopsy procedures for proper diagnosis. Further, the increasing incidence of colorectal cancer, one of the most recurrently diagnosed cancers globally, makes a major contribution to the need for GI biopsy devices. Furthermore, the growing use of image-guided biopsy methods, namely endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and fine-needle biopsy (EUS-FNB), improves diagnostic accuracy in deep-seated GI tumors, contributing to market growth. Moreover, rise in geriatric population suffering from GI disorders and advancements in healthcare infrastructure on a worldwide level favour market growth.
"Asia Pacific accounted for the fastest growing of the biopsy device market by region."
The global biopsy device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the fastest growing regional market for the biopsy device and is estimated to grow at the highest CAGR during the forecast period. The increasing incidence of cancer, coupled by demographic changes and lifestyle factors, has increased the need for early diagnosis, driving the use of biopsy procedures. Development of healthcare infrastructure, especially in nations such as China, India, and Japan, has increased access to sophisticated diagnostic technologies. Further, government initiatives and rising healthcare expenditures have also aided cancer screening programs, stimulating market growth. Moreover, the growing medical tourism industry in the region, specifically in countries with low-cost yet high-quality biopsy services, has also increased the growth in demand.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3- 25%
By Designation: C-level-35%, Director-level-25% and Others-40%
By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America- 10%, and Middle east and Africa-5%
Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the biopsy device market are BD (US), Devicor medical products, Inc (US), Medtronic (Ireland), Cardinal Health (US), B.Braun SE ( Germany), Hologic,Inc (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), Stryker (US), Teleflex Incorporated (US), CONMED Corporation (US), Merit Medical Systems (US), Johnson & Johnson Services,Inc. (US), Cook Group (US), MicroPort Scientific Corporation (China), Argon Medical Devices (US), INRAD, Inc (US), Summit Medical LLC (US), TransMed7, LLC (US), Dr. Japan Co., Ltd. (Japan), IZI Medical Products (US), Planmed Oy (Finland), Advin Health Care (India), Trivitron Healthcare (India).
Research Coverage
This report studies the biopsy device market based on product, type, technology, application end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Analysis of Key divers (Rising prevalence of cancer), restraints (Increasing product recalls), Challenge (Technological advancements), opportunity (Underdeveloped healthcare infrastructure in emerging economies)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the bbiopsy device market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the biopsy device market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the biopsy devices market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & GEOGRAPHIC SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 ASSESSMENT OF MARKET SEGMENTS
2.4 ASSESSMENT OF GEOGRAPHIC SEGMENTS
2.5 MARKET BREAKDOWN & DATA TRIANGULATION
2.6 RESEARCH ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES FOR PLAYERS IN BIOPSY DEVICES MARKET
4.2 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER
4.3 BIOPSY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
4.4 BIOPSY DEVICES MARKET: GEOGRAPHIC MIX
4.5 BIOPSY DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2024 VS. 2030 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of cancer
5.2.1.2 Increasing preference for minimally invasive surgeries
5.2.1.3 Initiatives undertaken by governments and global health organizations
5.2.1.4 Increased number of hospitals and diagnostic centers
5.2.1.5 Improved reimbursement policies
5.2.2 RESTRAINTS
5.2.2.1 Increasing product recalls
5.2.2.2 High risk of infections
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.3.2 Growing investments in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Underdeveloped healthcare infrastructure in emerging economies
5.3 INDUSTRY TRENDS
5.3.1 MINIMALLY INVASIVE PROCEDURES
5.3.2 ROBOTIC-ASSISTED BIOPSY DEVICES
5.3.3 LIQUID BIOPSY TECHNOLOGY
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Robotic-assisted biopsy devices
5.4.1.2 Optical biopsy technologies
5.4.1.3 Minimally invasive biopsy devices
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Imaging technologies
5.4.2.2 Tissue analysis technologies
5.4.2.3 Artificial intelligence
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Digital pathology and AI integration
5.4.3.2 Precision medicine tools
5.4.3.3 Advanced needle and probe technologies
5.5 PORTER'S FIVE FORCES ANALYSIS
5.5.1 THREAT FROM NEW ENTRANTS
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT FROM SUBSTITUTES
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATIONS, BY REGION
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.1.2 Canada
5.6.1.2 Europe
5.6.1.3 Asia Pacific
5.6.1.4 Latin America
5.6.1.5 Middle East & Africa
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS IN BIOPSY DEVICES MARKET
5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.8 TRADE ANALYSIS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT
5.9.2 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION
5.10 KEY CONFERENCES & EVENTS
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 BUYING CRITERIA
5.12 BIOPSY DEVICES MARKET: UNMET NEEDS/EXPECTATIONS OF END USERS
5.13 ECOSYSTEM ANALYSIS
5.14 CASE STUDY ANALYSIS
5.14.1 CASE STUDY 1: DEVICELAB COLLABORATED WITH CLINICAL EXPERTS TO IDENTIFY LIMITATIONS OF EXISTING BREAST BIOPSY PROCEDURES
5.14.2 CASE STUDY 2: RESEARCHERS AT UNIVERSITY OF TWENTE DESIGNED ROBOTIC SETUP AND SOFTWARE ARCHITECTURE TO ASSIST RADIOLOGISTS IN TARGETING MRI-DETECTED SUSPICIOUS TUMORS
5.14.3 CASE STUDY 3: RESEARCH TEAM DESIGNED FLEXIBLE ROBOTIC SYSTEM FOR BIOPSY SAMPLING APPLIED TO HUMAN CORPSES PLACED INSIDE PROTECTIVE BODY BAGS
5.15 SUPPLY CHAIN ANALYSIS
5.16 ADJACENT MARKET ANALYSIS
5.16.1 BREAST BIOPSY DEVICES MARKET
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI ON BIOPSY DEVICES MARKET
6 BIOPSY DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 NEEDLE-BASED BIOPSY INSTRUMENT
6.2.1 CORE NEEDLE BIOPSY
6.2.1.1 Core needle biopsy device
6.2.1.1.1 Semi-automatic
6.2.1.1.1.1 Need for balance of user control and automated functionality in procedures to drive market
6.2.1.1.2 Automatic
6.2.1.1.2.1 Demand for efficiency and accuracy in biopsy procedures to boost growth
6.2.1.2 Core needle biopsy needle
6.2.1.2.1 Disposable
6.2.1.2.1.1 Need for infection control and safety concerns to boost growth
6.2.1.2.2 Reusable
6.2.1.2.2.1 Cost-effectiveness of reusable core biopsy needles to drive market
6.2.2 FINE NEEDLE ASPIRATION BIOPSY
6.2.2.1 Innovations in needle design, including thinner profiles and improved tip configurations, to drive market
6.2.3 VACUUM-ASSISTED BIOPSY
6.2.3.1 Increasing need for early and accurate cancer detection to drive market
6.3 VISUALIZATION DEVICE/SYSTEM
6.3.1 RISING PREVALENCE OF CANCER AND OTHER CHRONIC CONDITIONS TO DRIVE DEMAND FOR VISUALIZATION DEVICE
6.4 BRUSH BIOPSY INSTRUMENT
6.4.1 PREFERENCE FOR MINIMALLY INVASIVE BIOPSY PROCEDURES TO BOOST MARKET
6.5 BIOPSY ACCESSORY
6.5.1 BIOPSY FORECEP
6.5.1.1 General biopsy forcep
6.5.1.1.1 Demand for minimally invasive procedures and precise diagnostics to surge growth
6.5.1.2 Hot biopsy forecep
6.5.1.2.1 Unique ability of hot biopsy forecep to cut and coagulate tissue to support growth
6.5.2 TISSUE MARKER
6.5.2.1 Rising cases of breast cancer to boost market growth
6.5.3 LOCALIZATION WIRE
6.5.3.1 Ability of localization wire to detect precise target locations to drive growth
6.5.4 OTHER ACCESSORIES
6.6 ROBOTIC BIOPSY DEVICE
6.6.1 RAPID DEVELOPMENT OF ROBOTIC BIOPSY DEVICES TO BOOST GROWTH
